Corporate Governance

Depomed is committed to conducting its business in accordance with all legal and regulatory requirements and with the highest standards of ethical behavior. To this end, the company has developed a code of conduct to serve as a guide for all company employees and directors to help ensure lawful and ethical conduct.

Code of Conduct

  PDF

Guidelines

  PDF

Shareholder Communication Procedures

  PDF

Accounting, Audit and Internal Control Complaints and Concerns Procedures

  PDF

Committees

The company's board of directors manages the business and establishes overall company policies and standards as well as reviews the performance of management. To facilitate this process, the board has formed three oversight committees each with a charter that outlines the roles and responsibilities of each committee. The committee charters are provided below.

Audit Committee Charter

  PDF

Nominating and Corporate Governance Committee Charter

  PDF

Compensation Committee Charter

  PDF

Board Committee Composition
Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.
Chairperson Chairperson Committee Member Member Financial Expert Financial Expert
 Audit CommitteeCompensation CommitteeNominating and Corporate Governance Committee
Karen A. Dawes 
Karen A. Dawes
Committee Member   Committee Member
Jim Fogarty 
Jim Fogarty
  Chairperson  
Louis  J. Lavigne, Jr. 
Louis  J. Lavigne, Jr.
Chairperson Committee Member  
William T. McKee 
William T. McKee
Committee Member Committee Member Committee Member
Peter D. Staple 
Peter D. Staple
Committee Member Committee Member  
James L. Tyree 
James L. Tyree
  Committee Member Chairperson

DEPO (Common Stock)

Exchange
NASDAQ CM
Price
$5.90
Change (%)
 - 0.02 (0.34%)
Volume
810,698
Market Cap
$371,635,017

Data as of 09/22/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Powered By EDGAR Online, Inc.